SCHEMBL18291567

SCHEMBL18291567

Cc1ccc(CN2CCNCC2)nn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CXCR4 P61073 9/20 0.46
▸ LMNA P02545 1/20 0.46
▸ SIGMAR1 Q99720 1/20 0.44
▸ KDM5C P41229 1/20 0.42
▸ KDM4C Q9H3R0 1/20 0.42
▸ CHRM2 P08172 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ CHRM1 P11229 1/20 0.41
▸ ADRA2C P18825 1/20 0.41
▸ CCR2 P41597 1/20 0.41
▸ CXCL12 P48061 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ HRH3 Q9Y5N1 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.39
▸ BRD4 O60885 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ SLC6A4 P31645 1/20 0.39
▸ OPRD1 P41143 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18291540 0.79 CXCR4 (0.46) CXCR4LMNASIGMAR1KDM5CKDM4C
SCHEMBL20037955 0.79 CXCR4 (0.46) CXCR4LMNASIGMAR1KDM5CKDM4C
SCHEMBL20465102 0.79 CXCR4 (0.54) CXCR4MEN1KMT2AHRH3ALDH1A1
SCHEMBL20249218 0.79 CXCR4 (0.43) CXCR4LMNASIGMAR1KDM5CKDM4C
SCHEMBL20037457 0.79 CXCR4 (0.43) CXCR4LMNASIGMAR1KDM5CKDM4C
SCHEMBL21850860 0.78 SCD (0.40) CXCR4LMNASIGMAR1KDM5CKDM4C
SCHEMBL1089502 0.75 CXCR4 (0.65) CXCR4LMNASIGMAR1KDM5CKDM4C
SCHEMBL17996820 0.75 CXCR4 (0.65) CXCR4LMNASIGMAR1KDM5CKDM4C
SCHEMBL20160684 0.75 CXCR4 (0.49) CXCR4LMNASIGMAR1KDM5CKDM4C
SCHEMBL20038507 0.74 CXCR4 (0.44) CXCR4LMNASIGMAR1KDM5CKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016194831-A1 PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF 帝人ファーマ株式会社 2016-12-08 — — WO disclosed
Send feedback